Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
about
Epigenetic control of phospholipase A2 receptor expression in mammary cancer cellsLiposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo.Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs.Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.
P2860
Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
@en
type
label
Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
@en
prefLabel
Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
@en
P2093
P2860
P356
P1476
Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
@en
P2093
P2860
P304
P356
10.1021/MP500174P
P407
P577
2014-09-22T00:00:00Z